Search PubMed⌕ Search

Biomedical subjects

H Schicha

Publications and source records attributed to H Schicha.

At least 163 records · Page 9Linked to original sources

[Benefit/risk considerations in diagnostic nuclear medicine].

The potential radiation risk carried out by diagnostic nuclear medicine has to be compared with the potential diagnostic and/or therapeutic benefit. An undifferentiated consideration of collective doses and risks is inappropriate. On the contrary, several factors have to be considered: the age of the patients, the prevalence of pathological test results, and the potential benefit from the diagnosis. This paper presents statistical data and individual examples. In many cases benefit exceeds risk substantially. On the other hand in some cases restrictions of diagnostic radiology or nuclear medicine should be considered.

Humans↗

[99mTc-generator eluates: effects on the radiochemical purity of the labelling products].

Relatively sensitive kits--which are known for low tin content (HMPAO) or for a complicated chemical labelling procedure (MAG3)--were tested for their efficiency of labelling with eluates of different generators. The radiochemical purity of the labelling products was determined according to the manufacturer's instructions (HMPAO: Amersham Buchler, MAG3: Mallinckrodt Diagnostica) after adding the 99mTcO4- eluates from the different Tc-generators (Amersham Buchler, Mallinckrodt Diagnostica, CIS Biointernational). The radiochemical purity was determined by using radioanalytical methods such as high performance liquid chromatography, thin layer chromatography, paper chromatography and reversed phase chromatography. The quality of the three different generator eluates was sufficient for the labelling of HMPAO and MAG3. The small differences in quality did not limit the use in nuclear medical routine.

Isotope Labeling↗

[Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].

In contrast to the established nuclear imaging techniques magnetic resonance imaging (MRI) is only in the early phase of its application to detect viable myocardium after myocardial infarction. Although MRI techniques have only recently been employed to assess residual myocardial viability three approaches have been described to achieve this purpose: First, the use of signal intensity changes on spin-echo images with and without the application of contrast media to define irreversible injury to the myocardium in acute and subacute infarcts; second, measurement of metabolite concentrations within the infarct area using magnetic resonance spectroscopy, and third quantitation of myocardial thickness and systolic wall thickening in chronic infarcts with and without positive inotropic stimulation. When applying magnetic resonance techniques to detect viable myocardium by imaging techniques, it is useful to distinguish between acute infarcts and chronic infarcts that are more than 16 weeks old. After the time, practically all infarcts have healed and the necrotic myocardium has been transformed into scar tissue. MRI seems ideally suited to detect and characterize chronic myocardial scar and distinguish it from viable but hibernating myocardium because it clearly depicts the regional wall thinning which is a typical feature of transmural infarcts (Figure 1). In contrast, more recent infarcts, even if they are transmural and fail to show any contraction during systole, may not yet exhibit myocardial thinning. Therefore, simply depicting the acutely injured myocardium by MRI is not sufficient to differentiate between necrotic and stunned, but viable myocardium. On the other hand, an increase in signal intensity of acutely infarcted myocardium, which appears on T2 weighted spin-echo MR images only a few hours after occlusion of a coronary artery, can be used to determine the extent of irreversible myocardial damage (Figure 2). It is not clear, however, whether this area of increased myocardial signal intensity that is seen within the first week after the event only represents necrotic myocardium or incorporates some edematous viable myocardium in the infarct border zone. After three weeks, true infarct size may be more closely approximated by the area of increased signal intensity because the edema surrounding the infarct has presumably regressed and signal abnormalities are restricted to the pathologically determined infarct area. More recently, new pulse sequences and high field magnets permit separate observation of the endocardial and epicardial portion of the left ventricular wall. This may further improve the detection of residual viable cells which are preferentially located near the epicardium.(ABSTRACT TRUNCATED AT 400 WORDS)

Adenosine Triphosphate↗

[Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].

The determination of residual viability in regions of myocardial infarcts is of considerable clinical interest. In order to assess residual viability in regions with chronic myocardial infarction, 18 patients with anterior myocardial infarcts and 14 patients with inferior myocardial infarcts as confirmed by ECG and cine ventriculography underwent 99mTc-methoxyisobutyl-isonitrile single photon emission computed tomography (MIBI-SPECT) and 18F-fluoro-D-glucose positron emission tomography (FDG-PET). Tracer uptake was quantified in 13 segments for each patient (a total of 416 segments). MIBI uptake was normalized to the maximal uptake in the heart, FDG uptake was normalized to the maximal uptake of left ventricular segments with normal contraction by cine ventriculography and without significant stenosis of the coronary artery supplying this region. MIBI-SPECT scar and FDG-PET scar were defined as tracer uptake of less than 2.5 SD below mean values of a healthy control group. Both methods scored 258 segments concordantly viable and 74 segments concordantly scar; 61 segments were scored scar by MIBI-SPECT and viable by FDG-PET, 23 segments were scored viable by MIBI-SPECT and scar by FDG-PET (p < 0.0001). In patients with anterior myocardial infarction, 136 segments were scored viable and 53 segments were scored scar by both methods, 29 segments were scored scar by MIBI-SPECT and viable by FDG-PET, 16 were scored discordantly viable by MIBI-SPECT and scar by FDG-PET (p < 0.06).(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques.

Magnetic resonance techniques have only recently been employed to assess residual myocardial viability after myocardial infarction. Three approaches have been described to achieve this purpose: First, the use of signal intensity changes on spin-echo images with and without the application of contrast media to define irreversible injury to the myocardium in acute and subacute infarcts; second, measurement of metabolite concentrations within the infarct area using magnetic resonance spectroscopy, and third, quantitation of myocardial thickness and systolic wall thickening in chronic infarcts. This paper reviews the pertinent literature and compares MR techniques with other imaging techniques used in the diagnosis of myocardial viability.

Acute Disease↗

Identification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile-SPECT.

Magnetic resonance imaging (MRI) has been used in conjunction with dipyridamole induced wall motion abnormalities for the noninvasive detection of coronary artery disease (CAD). To assess the clinical usefulness of dipyridamole-MRI for the localization of CAD and to evaluate the relation between dipyridamole induced wall motion abnormalities and myocardial perfusion 33 patients with severe CAD (> 70% diameter reduction) underwent MRI at rest and after dipyridamole infusion (0.75 mg dipyridamole/kg over a period of 10 minutes). All patients performed exercise stress testing and 20 patients of the study group additionally had rest and exercise stress 99mTc-methoxyisobutyl-isonitrile-SPECT (MIBI-SPECT). Two patients (6%) could not be evaluated due to severe motion artifacts during dipyridamole MRI. Segmental wall motion and perfusion of corresponding short axis planes were related to the major coronary arteries using a standardized segmental coronary artery perfusion pattern. Detection of wall motion abnormalities or perfusion defects by 2 blinded observers in consensus was the criterion for grading a segment normal or pathologic. For localization of CAD, segmental gradings were related to the presumed coronary artery territories. Stress-ECG was pathologic in 19/31 patients yielding a sensitivity of 61% and dipyridamole induced angina was present in 68% (21/31) of patients. Dipyridamole-MRI detected coronary artery disease with a sensitivity of 84% (26/31 patients) and all patients with new wall motion abnormalities also had dipyridamole induced angina. For the subgroup of 20 patients with MIBI-SPECT images, CAD was detected by both MIBI-SPECT and Dipyridamole-MRI in 90% (18/20) of patients. Dipyridamole-MRI and MIBI-SPECT gradings agreed in 55/60 (92%) coronary artery perfusion territories. There were no significant differences with respect to the sensitivities of Dipyridamole-MRI/MIBI-SPECT for the localization of individual coronary artery stenoses yielding 81%/78% for left anterior descending, 80%/80% for left circumflex and 92%/89% for right coronary artery stenoses. However, specificity of Dipyridamole-MRI (89%) for the detection of RCA stenoses was slightly better than for MIBI-SPECT (80%).

Coronary Angiography↗

[Dobutamine versus dipyridamole magnetic resonance tomography: safety and sensitivity in the detection of coronary stenoses].

Safety and sensitivity of gradient-echo magnetic resonance imaging (MRI) for the identification of significant coronary artery stenoses using pharmacologic stress testing was assessed in 61 patients with > or = 70% stenosis of a major coronary artery and a normal left ventricle. After MRI at rest 28 patients underwent dobutamine-MRI during steady-state dobutamine infusion (5, 10, 15 and 20 micrograms/kg/min) and 33 patients had dipyridamole-MRI after high-dose dipyridamole infusion (0.75 mg/kg over 10 min). All patients additionally performed standard ECG exercise stress testing (EST). Segmental wall motion analysis was performed in basal and midventricular short axis tomograms by two observers. A segment was graded pathologic if transient dobutamine or dipyridamole induced wall motion abnormalities could be detected. For comparison to coronary angiography findings, each segment was assigned to one of the coronary artery perfusion territories. There were no serious side-effects during dobutamine and dipyridamole infusion leading to termination of the study protocol. Peak double product during dobutamine infusion was significantly higher (p < 0.001) than after dipyridamole infusion (18.493 +/- 4.311 versus 12.799 +/- 2.694 mm Hg/min). Overall sensitivity of dobutamine and dipyridamole-MRI for coronary artery disease (CAD) was 85% and 84%. Regional asynergy by dobutamine and dipyridamole-MRI was observed in 73% versus 79% patients with single- and 100% versus 92% with multi-vessel disease. Individual coronary artery stenoses were correctly identified by segmental wall motion abnormalities in 87% versus 81% for left anterior descending, 62% versus 86% for left circumflex and 78% versus 92% for right coronary artery stenoses. In conclusion, dobutamine and dipyridamole-MRI are well tolerated and safe non-exercise dependent tests for detection and localization of hemodynamically significant coronary artery stenoses with a similar diagnostic accuracy but with a better control of stress intensity and duration provided by dobutamine.

Adult↗

[Frequency and temporal occurrence of a functional autonomy in recurring goiter].

In 168 patients who underwent thyroid surgery due to a goitre the frequency and the temporal occurrence of functional autonomy in recurrent goitres were determined retrospectively. The diagnosis of functional autonomy was established by quantitative suppression scintigraphy with 99mTc. In the region examined the limiting value for functional autonomy is 1.0% 99mTcU after suppression. In 41% (n = 69) of the patients a recurrent goitre was found in the clinical examination. The postoperative observation period in this patient group ranged from 2 months to 42 years with an average of 13.8 years. Whereas the prevalence of functional autonomy in the early postoperative years was low, a continuous increase of thyroid autonomy with values of about 4% per year could be found until the 20th postoperative year, the rate of patients with functional autonomy was then about 70%. Thereafter the prevalence of thyroid autonomy increased only marginally and reached about 90% in the 40th postoperative year. The results demonstrate that functional autonomies in recurrent goitres are frequent. The majority of examined patients had recurrent and not residual autonomies.

Adult↗

[Radioiodine therapy in Europe--a survey].

Treatment with 131I is a well known and widely accepted therapy for benign thyroid disease and thyroid cancer. High dose 131I therapy for ablative reasons in well-differentiated thyroid cancer is done mostly in hospitals with controlled area and adequate equipment for radiation protection. Low-dose therapies, however, of hyperthyroidism, thyroid autonomy and goiter may be done in out-patients in many countries. Limits of radioactivity administered for an ambulant therapy are varying. In Germany, 131I therapy of out-patients is generally not permitted. As many patients are waiting for a therapy but capacity is too low, waiting lists up to several months exist. This leads to a kind of medical tourism into other countries where therapy of out-patients is possible. This is a crucial point with regard to optimal medical care as well to health economics. This paper presents the results of a questionnaire which was sent to the national EANM delegates of all European countries. There is a great variability among these countries which indicates the different views handling of radioactivity and radiation protection. A more detailed questionnaire about regulatory and administrative rules initiated by an EANM task group for risk assessment in nuclear medicine is on the way.

Ambulatory Care↗

[31P-magnetic resonance spectroscopy: impaired energy metabolism in latent hyperthyroidism].

31Phosphorus magnetic resonance spectroscopy allows an in vivo examination of energy metabolism. The present study was designed to evaluate whether in patients with latent hyperthyroidism alterations of muscle energy metabolism could be found similar to those observed in patients with overt hyperthyroidism. In 10 patients with overt hyperthyroidism before therapy and 20 with latent hyperthyroidism (also without therapy) and in 24 healthy volunteers magnetic resonance spectroscopy of the calf muscle was performed within a 1.5-Tesla magnet. Muscle concentrations of phosphocreatine, inorganic phosphate, and ATP were quantified compared to an external standard solution of K2HPO4. In the patients with overt hyperthyroidism and with latent hyperthyroidism a significant decrease of phosphocreatine was found. Further, the ATP concentration in patients with latent and manifest hyperthyroidism tended towards lower values. There were no significant differences in the decrease of phosphocreatine and ATP between both patient groups. Therefore, this study for the first time shows that alterations of energy metabolism in latent hyperthyroidism can be measured and that they are similar to those observed in overt hyperthyroidism.

Adult↗

[The treatment of thyroid diseases using 131I in a special ward with a liquid waste storage plant].

This paper deals with the calculation of doses for organs of special interest under 131I treatment of thyroid diseases. Also the effective dose equivalent to the body of the patient, exclusive of the thyroid, is given. The ratio between the exposure by self-irradiation and the exposure from another patient in 2 m distance both having undergone 131I treatment with 50% uptake, is about 1000:1. Therefore positioning of a lead shield between two such patients in the same room is, from the point of view of radiation protection, unnecessary. A complete mathematical description of iodine distribution in a nuclear medicine ward and its liquid waste storage plant is given. The use in the authors' own department of these equations is demonstrated. Computer programs for additional calculations are available.

Humans↗

Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.

Somatostatin receptors have been demonstrated on various tumors of neuroendocrine and other origin. They have been detected in vitro by biochemical techniques as well as by autoradiography. The development of long-acting somatostatin analogs and the recent availability of radiolabeled octreotide have made the in vivo detection of somatostatin receptors possible. This preliminary study embraced 45 patients with meningiomas, brain tumors or pituitary tumors, which were imaged by planar and tomographic scintigraphy after intravenous injection of 111Indium-labeled octreotide. In all of the meningiomas studied (unifocal and multifocal tumors in various locations), a high density of somatostatin receptors was detected by scintigraphy. Pituitary tumors were slightly positive in 50% of cases only, independent of the endocrine activity. Gliomas with an intact blood-brain barrier showed no enhanced tracer uptake in vivo, while gliomas with disturbed blood-brain barrier had a high activity uptake. We conclude that in vivo somatostatin receptor scintigraphy, although not tumor-specific, may aid in the preoperative diagnosis and staging of intracranial tumors, especially skull base tumors.

Adult↗

[Immunogenic hyperthyroidism following radioiodine ablation of a focal autonomy].

Immunogenic hyperthyroidism rarely develops after radioiodine elimination of focal autonomous thyroid tissue. We observed this phenomenon in 8 patients between 1989 and 1992. The occurrence of immunogenic hyperthyroidism shortly after elimination of autonomous nodules has not been studied nor is it properly understood. Most studies known today describe the development of autonomous nodules in the course of immunogenic hyperthyroidism or ignore the chronologic order of occurrence. The possibility that immunogenic hyperthyroidism may occur after radioiodine therapy of autonomous nodules, makes a consequent follow-up within the first year following radioiodine therapy mandatory.

Aged↗

[The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].

The aim of this study was to determine the significance of the radioiodine uptake test for predicting the kinetics of therapeutic 131I doses in the treatment of benign thyroid disorders. We studied retrospectively the histories of 518 consecutive patients treated with 131I for hyperthyroidism or autonomous thyroid goiter, with respect to uptake and effective half-life of tracer and therapeutic doses. The mean half-life and uptake of the therapeutic doses were significantly smaller than that of the tracer dose. A comparison of different methods of calculation showed that the radioiodine uptake test is indispensible for dose calculation in radioiodine treatment but a single measurement after 24 or 48 h is sufficiently accurate because, on average, the therapeutic dose was achieved as planned and with the smallest scatter. Average half-lives specific to the disease to be treated may be used in the calculations.

Adult↗

Feasibility of high-dose dipyridamole-magnetic resonance imaging for detection of coronary artery disease and comparison with coronary angiography.

To assess the feasibility, safety and usefulness of gradient-echo magnetic resonance imaging (MRI) combined with pharmacologic stress testing for the detection of coronary artery disease, 23 patients without previous myocardial infarction but with significant stenosis (greater than 70% diameter stenosis) of greater than or equal to 1 major coronary artery were selected for dipyridamole-MRI stress testing. Each patient underwent MRI at rest, and high-dose dipyridamole-MRI (0.75 mg/kg over 10 minutes) of corresponding basal and midventricular short-axis tomograms. Additionally, these patients performed symptom-limited exercise stress tests. All short-axis tomograms were evaluated on a standardized segmental basis by grading each segment as normal, hypokinetic, akinetic or dyskinetic. Dipyridamole-MRI was considered pathologic if segmental wall motion deteriorated by greater than or equal to 1 grade after dipyridamole. For comparison with coronary angiography, segmental wall motion gradings were related to the respective coronary artery territories in the short-axis plane. Pathologic dipyridamole-MRI was obtained in 18 of 23 (78%) patients. For 1- and 2-vessel diseases, sensitivity was 69 and 90%, respectively. Exercise stress tests were pathologic in 14 of 23 (66%) patients. For 1- and 2-vessel diseases, sensitivity of exercise stress test was 58% (7 of 12 patients) and 77% (7 of 9), respectively. Sensitivity/specificity of dipyridamole-MRI for the localization of the stenosed coronary artery was 78/100% for left anterior descending, 73/100% for left circumflex, and 88/87% for right coronary artery stenoses. It is concluded that dipyridamole-MRI is a feasible nonexercise-dependent test for detection and localization of functionally significant coronary artery disease.

Aged↗

Chronic myocardial infarction: assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT.

To assess the ability of magnetic resonance imaging (MRI) to identify the anatomic and functional abnormalities associated with completely scarred myocardium, 20 patients with chronic transmural myocardial infarction confirmed by electrocardiography and cineventriculography were examined by gradient echo MRI. Myocardial perfusion at rest was assessed in corresponding transverse sections using 99mTc-methoxyisobutyl-isonitrile single-photon emission computed tomography (MIBI-SPECT). MRI scar was defined as diastolic wall thickness (DWT) 2.5 SD below corresponding normal values or systolic wall thickening (delta WT) less than or equal to 1 mm. For MIBI-SPECT images, scar was defined as a MIBI uptake less than 2.5 SD below normal values. By MIBI-SPECT, 152 segments contained normal tissue and 88 contained scarred myocardium. In 226 of 240 (94%) segments, MRI gradings by DWT and MIBI-SPECT gradings were identical. DWT by MRI was higher in normal than in scarred MIBI-SPECT segments (10 +/- 1 versus 4 +/- 2 mm, p less than 0.001). In 230 of 240 (96%) segments, MRI gradings by delta WT and MIBI-SPECT gradings were identical. Segments graded normal by MIBI-SPECT showed higher delta WT by MRI than scar segments (5 +/- 1 versus 0.3 +/- 1 mm, p less than 0.001). MIBI-SPECT perfusion defect size and regions with reduced DWT on MRI tomograms correlated well (r = 0.85). This study indicates that myocardial regions fulfilling electrocardiographic and ventriculographic criteria for transmural myocardial scar are clearly depicted by regional diastolic wall thinning and delta WT less than or equal to 1 mm on gradient echo MR images.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗